Scale assesses satisfaction with life among patients with food allergy
Click Here to Manage Email Alerts
Key takeaways:
- Satisfaction with life indicates how patients cognitively evaluate their own lives.
- Satisfaction is linked to distresses that can grow in a context of constant fear and to indicators of a healthier life.
Unlike other assessments, the Food Allergy Satisfaction with Life Scale assesses how individuals impacted by food allergy cognitively evaluate their own lives, according to a letter published in Clinical and Translational Allergy.
Other questionnaires address objective factors that can influence well-being and miss this self-reflection, Gabriel Lins de Holanda Coelho, PhD, postdoctoral researcher, School of Applied Psychology, University College Cork, and colleagues wrote.
As a construct, satisfaction with life is negatively linked to a range of distresses including depression, stress and suicide ideation that can grow in a context of constant fear, which many patients with food allergy experience, the researchers said.
But satisfaction with life also is positively linked to optimism, self-esteem and other indictors of a healthier life, the researchers continued.
The researchers adapted the five items in the Satisfaction with Life Scale to focus on food allergy and facilitate the measurement of the specific impact that food allergy has on satisfaction with life. The five items include:
- “In most ways, my life with a food allergy is close to my ideal.
- The conditions of my life with food allergy are excellent.
- I am satisfied with my life with food allergy.
- So far, I have all the important things I want in my life, despite my food allergy.
- If I could live my life over, I would change almost nothing, including my food allergy.”
Using the Prolific crowdsourcing platform, the researchers administered the Food Allergy Satisfaction with Life Scale (FASWLS), the Food Allergy Quality of Life Questionnaire (FAQLQ) and the Food Allergy Anxiety Scale (FAAS) to 201 patients (63.7% women; mean age, 37.12 years).
These patients all had a food allergy diagnosis, including 50.7% diagnosed by a general practitioner and 27.4% diagnosed by an allergist, and 73.6% reporting a severe allergic reaction. Allergens included peanut (39.3%), tree nuts (33.8%) and shellfish (18.9%).
The unidimensional structure of the FASWLS had a good model fit, the researchers said, with a comparative fit index of 0.98, a Tucker-Lewis index of 0.96 and a standardized root mean square residual of 0.027. Factorial loadings ranged from 0.6 for the fifth item on the FASWLS to 0.9 for the second item.
A Cronbach’s alpha score of 0.88 and a McDonald’s omega score of 0.89 indicated that the FASWLS also had good reliability, the researchers continued. Additionally, the FASWLS negatively correlated with the FAAS (r = –0.51; P < .001).
The FASWLS positively correlated with all the factors in the FAQLQ as well, which included emotional impact (r = 0.52), health (r = 0.47), risk (r = 0.48) and social and dietary limitations (r = 0.58; P < .001 for all).
Overall, the researchers said, participants with higher scores pertaining to satisfaction with food allergy life also had lower scores for food allergy anxiety and higher scores for food allergy quality of life, validating the FASWLS as a psychometrically sound scale.
Further, the researchers said, the FASWLS can enhance research in health-related quality of life by providing a focused understanding of the link between food allergy and satisfaction with life.
For example, the researchers said, a patient could have a high food allergy health-related quality of life score because they have a low perceived risk but still have a low FASWLS score because of the presence of food allergy and the burdens it brings.
Other current questionnaires that specifically assess food allergy do not assess this subjective construct, the researchers continued. But the FASWLS provides a standardized approach for doing so for a broader and more comprehensive analysis of food allergy’s impact on the individual patient.
By resolving knowledge gaps and driving patient-centered innovations in treatment, practice and policy, the researchers concluded, the FASWLS will benefit researchers, clinicians and patients.